The approval of subcutaneous amivantamab allows physicians flexibility in offering treatment for non–small cell lung cancer.

Excess abdominal fat, particularly visceral fat, actively triggers morning blood sugar spikes by causing liver insulin ...

VKTX remains a Buy for its cheap FY2030 EV/Sales valuations of 2.28x, the strong clinical trial results exceeding legacy ...

The top 10 PharmTech videos of the year cover advanced therapies, high-concentration biologics, major mergers and ...

Nigerian women are choosing modern contraceptives over tradition for their health and economic survival. Discover the ...

Fat in the body is not a recommended thing, but there is one type of fat that is truly dangerous. What leads to its ...

Get the latest U.S. stock market and healthcare sector updates, key company news, and top healthcare winners and losers.

Seers Technology, D&D Pharmatech, OliX, ABL Bio. Among the top 10 stocks by share price growth this year, four were ...

Indians can develop central obesity even at lower weights, indicating that a “normal” BMI can miss early risk, says Makhija.